Literature DB >> 25312870

Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: their role in the prediction of vascular complications.

Amal Zaghloul1, T A M A Al-Bukhari2, H A Al-Pakistani2, Maged Shalaby2, Saeed H Halawani2, Nada Bajuaifer2, Shirin H Teama3.   

Abstract

BACKGROUND AND
OBJECTIVE: Endothelial dysfunction in diabetes mellitus (DM) is an important factor in the pathogenesis of micro and macrovascular complications. We aimed to measure soluble endothelial protein C receptor (sEPCR) and high sensitivity C reactive protein (hsCRP) levels as markers of endothelial damage in both types of diabetes mellitus and to determine if they can be used as predictors of vascular complications.
METHODS: Fifty patients with DM, 20 with type 1 and 30 with type 2 as well as 30 healthy subjects were included. All were subjected to measurement of sEPCR and hsCRP by enzyme linked immunosorbent assay.
RESULTS: sEPCR and hsCRP were significantly increased when compared to the control group in both types of DM. sEPCR was a significant predictor of macrovascular complications and thrombosis in type 1 p=0.02, and p=0.015, respectively. hsCRP was a significant predictor of macrovascular complications in type 2 p=0.04.
CONCLUSION: Patients with type 1 and type 2 DM exhibit higher sEPCR and hsCRP levels compared to healthy controls which suggesting endothelial damage. sEPCR could be used as a predictor of macrovascular complications and thrombosis in type 1 DM, whereas, hsCRP might be used as a predictor of macrovascular complications in type 2 DM.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Vascular complications; hsCRP; sEPCR

Mesh:

Substances:

Year:  2014        PMID: 25312870     DOI: 10.1016/j.diabres.2014.09.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus.

Authors:  A E Berezin; A A Kremzer; T A Samura; T A Berezina; P Kruzliak
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

2.  The signature of circulating microparticles in heart failure patients with metabolic syndrome.

Authors:  Alexander E Berezin; Alexander Kremzer; Tatyana Berezina; Yu Martovitskaya
Journal:  J Circ Biomark       Date:  2016-11-10

3.  Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers.

Authors:  Asmaa M Zahran; Sohair K Sayed; Heba A Abd El Hafeez; Walaa A Khalifa; Nahed A Mohamed; Helal F Hetta
Journal:  Diabetes Metab Syndr Obes       Date:  2019-04-12       Impact factor: 3.168

4.  The human type 2 diabetes-specific visceral adipose tissue proteome and transcriptome in obesity.

Authors:  Nicholas J Carruthers; Clarissa Strieder-Barboza; Joseph A Caruso; Carmen G Flesher; Nicki A Baker; Samuel A Kerk; Alexander Ky; Anne P Ehlers; Oliver A Varban; Costas A Lyssiotis; Carey N Lumeng; Paul M Stemmer; Robert W O'Rourke
Journal:  Sci Rep       Date:  2021-08-30       Impact factor: 4.379

Review 5.  A Useful Blood Flow Restriction Training Risk Stratification for Exercise and Rehabilitation.

Authors:  Dahan da Cunha Nascimento; Nicholas Rolnick; Ivo Vieira de Sousa Neto; Richard Severin; Fabiani Lage Rodrigues Beal
Journal:  Front Physiol       Date:  2022-03-11       Impact factor: 4.566

6.  Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation.

Authors:  Alexander E Berezin; Alexander A Kremzer; Tatyana A Berezina; Yulia V Martovitskaya
Journal:  BBA Clin       Date:  2015-08-03

7.  A study of the correlation of insulin resistance and leptin with inflammatory factors and vascular endothelial injury in T2DM patients with CHD.

Authors:  Jie Zhang; Jing Jin; Jilun Liu; Yajun He; Peng Zhang; Wucheng Ye; Wei Zhu; Mingliang Li
Journal:  Exp Ther Med       Date:  2018-05-16       Impact factor: 2.447

8.  High Sensitivity C-Reactive Protein Predictive Value for Cardiovascular Disease: A Nested Case Control from Isfahan Cohort Study (ICS).

Authors:  Pooya Koosha; Hamidreza Roohafza; Nizal Sarrafzadegan; Mehrbod Vakhshoori; Mohammad Talaei; Erfan Sheikhbahaei; Masoumeh Sadeghi
Journal:  Glob Heart       Date:  2020-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.